International Symposium on Organic Chemistry and Drug Design (ISOC-DD - 26)

This track focuses on the latest developments in medicinal chemistry, emphasizing novel drug candidates and therapeutic strategies. Participants will explore innovative approaches to drug design and optimization.

This session highlights cutting-edge synthetic methodologies in organic chemistry, including novel reactions and techniques. Attendees will discuss the implications of these strategies for pharmaceutical applications.

This track examines the intersection of chemical biology and drug discovery, showcasing how chemical tools can elucidate biological mechanisms. Researchers will present case studies on the application of chemical biology in developing new therapeutics.

Focusing on molecular design, this session will delve into structure-activity relationships (SAR) that guide the optimization of drug candidates. Participants will share insights on computational and experimental approaches to SAR analysis.

This track addresses recent innovations in pharmaceutical chemistry, including formulation strategies and delivery systems. Discussions will center on how these innovations enhance drug efficacy and patient compliance.

This session emphasizes the role of computational chemistry in drug design, including molecular modeling and simulation techniques. Researchers will present their findings on how computational tools can streamline the drug development process.

This track explores organic synthesis techniques specifically tailored for pharmaceutical applications. Presentations will cover the synthesis of complex molecules and their relevance to drug development.

Focusing on chemical innovation, this session will showcase novel therapeutic agents and their mechanisms of action. Participants will discuss the challenges and successes in bringing innovative drugs to market.

This track highlights emerging trends in synthetic chemistry, including green chemistry and sustainable practices. Attendees will explore how these trends impact drug design and production.

This session addresses the regulatory landscape surrounding pharmaceutical chemistry, focusing on compliance and safety considerations. Experts will discuss the implications of regulations on drug development and market entry.

This track emphasizes the importance of translational research in organic chemistry, bridging the gap between laboratory discoveries and clinical applications. Participants will share successful case studies that illustrate this critical connection.